Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0094 | 5.52941176471 | 0.17 | 0.2252 | 0.165 | 27420289 | 0.19910418 | CS |
| 4 | -0.2606 | -59.2272727273 | 0.44 | 0.44 | 0.121 | 34565248 | 0.2016302 | CS |
| 12 | -0.5026 | -73.6950146628 | 0.682 | 0.7345 | 0.121 | 11781687 | 0.20286696 | CS |
| 26 | -0.4726 | -72.4846625767 | 0.652 | 0.89 | 0.121 | 5098970 | 0.20511367 | CS |
| 52 | -2.8706 | -94.1180327869 | 3.05 | 3.33 | 0.121 | 2580200 | 0.22320871 | CS |
| 156 | -21.0206 | -99.1537735849 | 21.2 | 26.6 | 0.121 | 1027733 | 2.58519304 | CS |
| 260 | -95.0206 | -99.8115546218 | 95.2 | 123.6 | 0.121 | 1368181 | 25.29184438 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
